Snehi Sagarika

Snehi Sagarika, Thattaruthody Faisal, Singh Jyoti, Singh Ashok, Pandav Surinder S, Kaushik Sushmita

This study found that Ab Interno Bleb Revision (AIBR) effectively restores failed trabeculectomy blebs, significantly lowering IOP and medication needs, offering a safe, minimally invasive option for patients.

Choudhary Sandeep, Snehi Sagarika, Singh Ashok, Thattaruthody Faisal, Pandav Surinder Singh, Kaushik Sushmita

This study found low-cost torchlight-guided TSCPC effectively reduced IOP and medication in pediatric glaucoma, requiring less laser energy and oral meds than unguided treatment, improving safety and accessibility.

Kaushik Sushmita, Luthra-Guptasarma Manni, Prasher Dimple, Dhingra Deepika, Singh Nirbhai, Kumar Aman et al.

Studying congenital glaucoma genetics, researchers found CYP1B1 mutations, especially c.1169G>A, are more common in severe neonatal-onset cases, explaining their worse prognosis compared to infantile-onset.

Kaushik Sushmita, Dhingra Deepika, Arora Atul, Singh Mini P, Kaur Savleen, Joshi Gunjan et al.

This study found early surgery for neonatal-onset glaucoma, often non-PCG, can yield good visual and IOP outcomes, emphasizing timely intervention and amblyopia therapy.

Dhingra Deepika, Ghai Babita, Sabharwal Pranshuta, Saini Vikas, Snehi Sagarika, Kaur Manpreet et al.

This study found 3.5 µg/kg intranasal dexmedetomidine is a more effective and safe sedative for pediatric glaucoma exams, potentially reducing the need for repeated general anesthesia.

Kaushik Sushmita, Dhingra Deepika, Vibha Badrinath, Saini Arshiya, Gupta Gaurav, Snehi Sagarika et al.

This study found neonatal-onset congenital ectropion uveae (N-CEU) is a distinct, severe form of newborn glaucoma with worse corneal clarity and poorer surgical outcomes than primary congenital glaucoma.